Empaphage (25mg) 14 Tablets
Empagliflozin 25mg tablets for type 2 diabetes.
Empaphage (25mg) 14 Tablets contains empagliflozin, an SGLT2 inhibitor for type 2 diabetes. The 25mg strength is for once-daily dosing. Take once daily as directed; may be taken with or without food.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when prescribed.
Ingredients
Empagliflozin 25mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections.
Side Effects
Urinary tract infections, genital mycotic infections, increased urination. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Martin DOW |
| Status | Active |